Trillium Trading (WOK) discloses 220,000 shares, 18% stake

Rhea-AI Filing Summary

Trillium Trading, LLC reported beneficial ownership of 220,000 Class A Ordinary Shares of WORK Medical Technology Group LTD, representing 18% of that class per this Schedule 13G. The filing states Trillium has sole voting and sole dispositive power over 220,000 shares. The filing lists issuer headquarters in Auckland, New Zealand.

Insights

Equity Ownership Analyst

Trillium holds a large, disclosed passive stake of 18% in WORK.

The filing lists 220,000 shares beneficially owned with sole voting and dispositive power. As a Schedule 13G filing, this indicates an ownership disclosure rather than an active acquisition narrative in the excerpt provided.

Future public filings may show any changes in position; this filing alone documents current ownership and control over voting and disposition for the stated shares.

Corporate Governance Specialist

Disclosure signals a significant shareholder with unilateral voting authority for the reported shares.

The filing identifies the holder and gives exact voting/dispositive counts—220,000 shares with sole power to vote and dispose. This level of ownership can give the holder influence in shareholder matters, subject to other holders' positions.

Any governance implications depend on other holders' stakes and whether the position is passive; additional filings would clarify changes or intentions.

Key Figures

Beneficial ownership: 220,000 shares Percent of class: 18% Sole voting power: 220,000 shares +2 more

5 metrics

Beneficial ownership 220,000 shares Class A Ordinary Shares

Percent of class 18% Percent of Class A Ordinary Shares

Sole voting power 220,000 shares Number of shares with sole voting power

Sole dispositive power 220,000 shares Number of shares with sole dispositive power

Filing/signature date 06/08/2026 Signature date on the excerpt

Key Terms

Schedule 13G, Beneficially owned, Sole dispositive power

3 terms

Schedule 13G regulatory

"Schedule 13G appears as the form type for the ownership disclosure"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Amount beneficially owned: 220000"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 220000"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/08/2026 - 03:08 PM Accepted by SEC EDGAR 06/08/2026 - 03:08 PM Learn about SEC filing dates

FAQ

What stake does Trillium Trading hold in WORK (WOK)?

Trillium Trading holds 220,000 Class A Ordinary Shares, which the filing states is 18% of that class. The Schedule 13G lists sole voting and sole dispositive power over those shares in the excerpt.

Does Trillium have voting control over its WORK shares?

Yes. The filing states Trillium has sole voting power for 220,000 shares and sole dispositive power for the same amount, indicating control over voting and disposition of those shares.

What document reports this ownership for WORK (WOK)?

The ownership is reported on a Schedule 13G disclosure submitted in connection with WORK Medical Technology Group LTD. The filing identifies Trillium Trading, LLC and provides ownership percentages and powers.

Where is WORK Medical Technology Group LTD headquartered as listed here?

The filing lists the issuer's principal executive offices at 1/88 COOK ST, AUCKLAND CITY, NEW ZEALAND, 1001. This address appears in the ownership disclosure extract provided.

Who signed the disclosure and when was it signed?

The filing excerpt is signed by Louis Capone, Compliance Officer, with a signature date shown as 06/08/2026 in the provided content.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

WORK Medical Technology Group LTD

(Name of Issuer)

Class A Ordinary Shares

(Title of Class of Securities)

G9767H125

(CUSIP Number)

06/03/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G9767H125

1

Names of Reporting Persons

Trillium Trading, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 220,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 220,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

220,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

18.0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: WORK Medical Technology Group LTD
(b)	Address of issuer's principal executive offices: 1/88 COOK ST, AUCKLAND CITY, NEW ZEALAND, 1001
Item 2.
(a)	Name of person filing: Trillium Trading, LLC
(b)	Address or principal business office or, if none, residence: 417 Fifth Avenue, New York, New York 10016
(c)	Citizenship: Limited liability company organized under the laws of the State of Delaware, United States of America
(d)	Title of class of securities: Class A Ordinary Shares
(e)	CUSIP Number(s): G9767H125
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 220000
(b)	Percent of class: 18%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 220000
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 220000
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Trillium Trading, LLC

Signature:	Louis Capone
Name/Title:	Compliance Officer
Date:	06/08/2026